Do integrase inhibitors raise the risk of obesity?
Improved liver function, but progressive kidney damage, among children on antiretroviral therapy in Ethiopia
Italian study shows growth in heart and kidney problems in people living with HIV
Doubt cast on link between tenofovir disoproxil and bone fractures
How safe is PrEP? Meta-analysis finds no increased risk of serious side-effects
Wide range of views about switching to weekly, monthly or biannual ART
Efavirenz, but not dolutegravir, linked to neurological problems in children
Neuropsychiatric side-effects lead only 1 in 40 to drop dolutegravir, French study shows
Diarrhoea continues to affect the quality of life of people with HIV in the modern treatment era
